Related Experiment Video
Updated: Apr 18, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Nicotine withdrawal.
Ian McLaughlin1, John A Dani, Mariella De Biasi
1Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Nicotine withdrawal symptoms emerge after quitting, influenced by consumption methods and genetic factors. Understanding these genetic predispositions and neural pathways can lead to personalized addiction treatments.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Chronic nicotine use leads to aversive abstinence syndrome upon cessation.
- Withdrawal symptoms manifest within hours, peak around day 3, and persist for weeks.
Purpose of the Study:
- To investigate genetic predispositions and neural mechanisms underlying nicotine withdrawal.
- To identify targets for personalized nicotine addiction therapeutics.
Main Methods:
- Analysis of short nucleotide polymorphisms (SNPs) associated with nicotine consumption and withdrawal severity.
- Utilizing rodent behavioral and transgenic mouse models to study nicotinic acetylcholine receptor (nAChR) subunits, cellular components, and neuronal circuits.
Main Results:
- Specific SNPs are linked to increased nicotine consumption and more severe withdrawal symptoms.
- nAChR subunits, cellular components, and neuronal circuits are critical for withdrawal expression.
Conclusions:
- Mapping neuronal circuits and nAChR subpopulations is key to understanding nicotine withdrawal.
- Identifying predisposing genes will enable personalized treatments for nicotine addiction and withdrawal.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...